Sponsored

The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.

As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.